Orthofix International NV  

(Public, NASDAQ:OFIX)   Watch this stock  
Find more results for Luke T. Faulstick
+0.40 (1.31%)
Dec 19 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 30.17 - 31.09
52 week 20.23 - 36.90
Open 30.39
Vol / Avg. 133,119.00/135,398.00
Mkt cap 570.24M
P/E     -
Div/yield     -
EPS -1.27
Shares 18.44M
Beta 0.74
Inst. own 93%
Sep 25, 2014
Orthofix International NV Finance and Restatement Update - Conference Call
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin -0.22% -3.72%
Operating margin 2.43% -1.27%
EBITD margin - 9.18%
Return on average assets -0.21% -3.33%
Return on average equity -0.28% -4.40%
Employees 889 -
CDP Score - -


7 Abraham de Veerstraat
+599-9-4658525 (Phone)
+599-9-4616978 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Orthofix International N.V. (Orthofix) is a diversified, global medical device company focused on developing and delivering repair and regenerative solutions to the spine and orthopedic markets. The Company operates in two global business units, which include Spine and Orthopedics. It designs, develops, manufactures, markets and distributes medical equipment used principally by musculoskeletal medical specialists for spine and orthopedic applications. Its main products are spinal implant products and related human cellular and tissue based products (HCT/P products) used in surgical procedures, non-invasive regenerative stimulation products used to enhance bone growth and the success rate of spinal fusions and to treat non-union fractures, external and internal fixation devices used in fracture repair, limb lengthening and bone reconstruction.

Officers and directors

Ronald A. Matricaria Independent Chairman of the Board
Bio & Compensation  - Reuters
Bradley R. Mason President, Chief Executive Officer, Director
Age: 60
Bio & Compensation  - Reuters
Davide Bianchi President - Global Extremity Fixation
Age: 49
Bio & Compensation  - Reuters
Doug Rice Interim Chief Financial Officer, Chief Accounting Officer
Age: 49
Bio & Compensation  - Reuters
Jeffrey M. Schumm Senior Vice President, General Counsel, Corporate Secretary
Age: 52
Bio & Compensation  - Reuters
Michael M. Finegan Chief Strategy Officer
Age: 50
Bio & Compensation  - Reuters
Luke T. Faulstick Director
Age: 49
Bio & Compensation  - Reuters
James F. Hinrichs Independent Director
Age: 47
Bio & Compensation  - Reuters
Guy J. Jordan Ph.D. Independent Director
Age: 65
Bio & Compensation  - Reuters
Anthony F. Martin Ph.D. Independent Director
Age: 59
Bio & Compensation  - Reuters